Skip to content
PubMed This is a summary of 96 peer-reviewed journal articles Updated
Cardiology

Pancreatic hypoplasia-diabetes-congenital heart disease syndrome: A Patient Guide

At a Glance

GATA6-related disorder is a rare genetic condition that can affect the heart and pancreas, leading to congenital heart disease, diabetes, or digestive problems. Features vary widely, so treatment is tailored and may include insulin, pancreatic enzymes, and specialist monitoring.

Pancreatic hypoplasia-diabetes-congenital heart disease syndrome is a rare genetic condition that affects the early development of several vital organ systems. Most often associated with a pathogenic variant in the GATA6 gene, this syndrome (often referred to as a GATA6-related disorder) serves as a reminder of how early genetic blueprints guide the construction of the heart and digestive organs [1].

The condition is characterized by three possible “pillars”: the heart, blood sugar regulation, and digestion. In the heart, the genetic change can disrupt the formation of major blood vessels and internal walls, leading to structural defects that are often present at birth [2]. At the same time, the pancreas—the organ responsible for making insulin and digestive juices—may be smaller than usual (hypoplasia) or missing entirely (agenesis) [3]. If the pancreas is severely affected, the body may not be able to maintain healthy blood sugar levels, leading to neonatal diabetes, nor can it properly break down fats and nutrients from food [4]. Importantly, this is a spectrum: not every person has congenital heart disease, diabetes at birth, or clinically significant digestive issues.

One of the most important things to understand about this syndrome is its variable expressivity, or the “dimmer switch” effect. Even within the same family, two people with the exact same genetic variant may have very different experiences [5]. One person might be born with a complex heart defect and early-onset diabetes, while another might have only a mild heart murmur or develop diabetes much later in adulthood [6]. Because the syndrome is so rare, it is normal to find that local doctors have limited experience with it, making it essential to connect with a specialized care team that understands these unique patterns [7].

Living with this condition is focused on monitoring the organs that need support and replacing what the body cannot produce on its own. This typically involves insulin therapy if diabetes is diagnosed, and pancreatic enzyme replacement when digestive insufficiency is demonstrated [8]. While the diagnosis is complex, modern medicine allows specialists to tailor treatments to your child’s—or your own—specific needs, so that individuals with this syndrome can thrive [4].

Common questions in this guide

What is pancreatic hypoplasia-diabetes-congenital heart disease syndrome?
It is a rare genetic condition, most often linked to a disease-causing change in the GATA6 gene. The change can affect formation of the pancreas and heart and may cause diabetes or difficulty digesting nutrients, but the combination and severity vary from person to person.
Does everyone with a GATA6-related disorder have heart defects and diabetes?
No. The condition has a broad range of features: some people have a heart defect and diabetes from infancy, whereas others have a mild heart murmur, develop diabetes later, or have no clinically important heart or digestive problems. Even people in the same family with the same GATA6 variant can be affected differently.
What treatments are used when the pancreas is affected?
Insulin therapy may be needed when the pancreas does not make enough insulin and diabetes is present. Pancreatic enzyme replacement is used when digestive insufficiency is demonstrated, and the care team adjusts treatment to the person’s needs.
Why might my child need several specialists?
GATA6-related disorder can affect the heart, blood sugar, and digestion, so care may involve cardiology, endocrinology, and digestive specialists. A primary care coordinator can organize appointments and help the team consider changes in one area, such as improved digestion and weight gain, when insulin is adjusted.
Should family members have genetic testing?
A genetic counselor can review the specific GATA6 variant and explain whether testing relatives would be useful and appropriate. The recommendation depends on the variant and each person’s family and medical history.
What should be monitored over time?
Monitoring is tailored to the person’s features and may include heart health, blood sugar, and digestion. The care team may also discuss what to do if signs involving the gallbladder or thyroid appear and which warning signs should prompt medical attention.

Get notified when new evidence is published on Pancreatic hypoplasia-diabetes-congenital heart disease syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    GATA6 Cooperates with EOMES/SMAD2/3 to Deploy the Gene Regulatory Network Governing Human Definitive Endoderm and Pancreas Formation.

    Chia CY, Madrigal P, Denil SLIJ, et al.

    Stem cell reports 2019; (12(1)):57-70 doi:10.1016/j.stemcr.2018.12.003.

    PMID: 30629940
  2. 2

    Congenital hypothyroidism, cardiac defects, and pancreatic agenesis in an infant with GATA6 mutation.

    Raghuram N, Marwaha A, Greer MC, et al.

    American journal of medical genetics. Part A 2020; (182(6)):1496-1499 doi:10.1002/ajmg.a.61569.

    PMID: 32207556
  3. 3

    Case report: adult onset diabetes with partial pancreatic agenesis and congenital heart disease due to a de novo GATA6 mutation.

    Sanchez-Lechuga B, Saqlain M, Ng N, et al.

    BMC medical genetics 2020; (21(1)):70 doi:10.1186/s12881-020-01012-2.

    PMID: 32245430
  4. 4

    The Identification of a Novel Pathogenic Variant in the GATA6 Gene in a Child with Neonatal Diabetes.

    Sechko EA, Koltakova MP, Khusainova RI, et al.

    International journal of molecular sciences 2024; (25(22)) doi:10.3390/ijms252211998.

    PMID: 39596087
  5. 5

    Case report: maternal mosaicism resulting in inheritance of a novel GATA6 mutation causing pancreatic agenesis and neonatal diabetes mellitus.

    Yau D, De Franco E, Flanagan SE, et al.

    Diagnostic pathology 2017; (12(1)):1 doi:10.1186/s13000-016-0592-1.

    PMID: 28049534
  6. 6

    Monogenic Diabetes with GATA6 Mutations: Characterization of a Novel Family and a Comprehensive Analysis of the GATA6 Clinical and Genetics Traits.

    Yue X, Luo Y, Wang J, Huang D

    Molecular biotechnology 2024; (66(3)):467-474 doi:10.1007/s12033-023-00761-8.

    PMID: 37204622
  7. 7

    A novel GATA6 variant in a boy with neonatal diabetes and diaphragmatic hernia: a familial case with a review of the literature.

    Gaisl O, Konrad D, Joset P, Lang-Muritano M

    Journal of pediatric endocrinology & metabolism : JPEM 2019; (32(9)):1027-1030.

    PMID: 31271559
  8. 8

    Successful Treatment of a Very Low-Birth-Weight Infant With GATA6 Neonatal Diabetes Using Continuous Subcutaneous Insulin Infusion.

    Ito T, Suzuki A, Yamaguchi N, et al.

    Cureus 2025; (17(5)):e83555 doi:10.7759/cureus.83555.

    PMID: 40476119

This page explains GATA6-related pancreatic, heart, blood-sugar, and digestive features for informational purposes only; it does not constitute medical advice. Ask your genetics, cardiology, diabetes, and digestive-care team to interpret your or your child’s findings and treatment needs.